OAM
TVTX icon

Oxford Asset Management’s Travere Therapeutics TVTX Stock Holding History

Oxford Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,428
Closed -$369K – 744
2025
Q3 		$369K Buy
+15,428
New +$290K 0.12% 299
2020
Q1 		– Sell
-103,202
Closed -$1.47M – 1233
2019
Q4 		$1.47M Buy
103,202
+90,067
+686% +$1.15M 0.04% 617
2019
Q3 		$152K Buy
+13,135
New +$217K ﹤0.01% 1601
2018
Q3 		– Sell
-28,700
Closed -$746K – 1930
2018
Q2 		$746K Sell
28,700
-41,040
-59% -$1.09M 0.01% 1182
2018
Q1 		$1.56M Buy
69,740
+12,502
+22% +$298K 0.03% 711
2017
Q4 		$1.21M Sell
57,238
-2,530
-4% -$57.8K 0.03% 842
2017
Q3 		$1.5M Buy
59,768
+24,906
+71% +$548K 0.03% 766
2017
Q2 		$676K Sell
34,862
-34,170
-49% -$620K 0.01% 1019
2017
Q1 		$1.27M Sell
69,032
-10,842
-14% -$212K 0.03% 712
2016
Q4 		$1.51M Sell
79,874
-80,801
-50% -$1.65M 0.05% 391
2016
Q3 		$3.6M Sell
160,675
-55,409
-26% -$1.05M 0.11% 224
2016
Q2 		$3.85M Buy
216,084
+8,322
+4% +$135K 0.13% 211
2016
Q1 		$2.84M Sell
207,762
-35,686
-15% -$541K 0.08% 294
2015
Q4 		$4.75M Buy
+243,448
New +$4.86M 0.11% 194

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's TVTX Position: Q4 2025 in Review

Oxford Asset Management sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 15,428 shares — an estimated $369K sold.

Oxford Asset Management first reported a position in TVTX in Q4 2015 and held it in 14 quarters. The position peaked at $4.75M in Q4 2015. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

  • Oxford Asset Management reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 15,428 Travere Therapeutics shares in Q4 2025, an estimated $369K.
  • Oxford Asset Management first reported a position in Travere Therapeutics in Q4 2015 and held it in 14 quarters.
  • Oxford Asset Management's Travere Therapeutics position peaked at $4.75M in Q4 2015.
  • 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.